Danaher Shares Outstanding 2010-2022 | DHR
Danaher shares outstanding history from 2010 to 2022. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Danaher shares outstanding for the quarter ending March 31, 2022 were 0.738B, a 0.35% increase year-over-year.
- Danaher 2021 shares outstanding were 0.737B, a 2.52% increase from 2020.
- Danaher 2020 shares outstanding were 0.719B, a 0.94% decline from 2019.
- Danaher 2019 shares outstanding were 0.726B, a 2.15% increase from 2018.
Danaher Annual Shares Outstanding (Millions of Shares) |
2021 |
737 |
2020 |
719 |
2019 |
726 |
2018 |
710 |
2017 |
706 |
2016 |
700 |
2015 |
709 |
2014 |
716 |
2013 |
711 |
2012 |
713 |
2011 |
701 |
2010 |
683 |
2009 |
671 |
Danaher Quarterly Shares Outstanding (Millions of Shares) |
2022-03-31 |
738 |
2021-12-31 |
737 |
2021-09-30 |
727 |
2021-06-30 |
736 |
2021-03-31 |
735 |
2020-12-31 |
719 |
2020-09-30 |
724 |
2020-06-30 |
718 |
2020-03-31 |
708 |
2019-12-31 |
726 |
2019-09-30 |
729 |
2019-06-30 |
728 |
2019-03-31 |
719 |
2018-12-31 |
710 |
2018-09-30 |
711 |
2018-06-30 |
710 |
2018-03-31 |
710 |
2017-12-31 |
706 |
2017-09-30 |
706 |
2017-06-30 |
705 |
2017-03-31 |
706 |
2016-12-31 |
700 |
2016-09-30 |
701 |
2016-06-30 |
699 |
2016-03-31 |
697 |
2015-12-31 |
709 |
2015-09-30 |
699 |
2015-06-30 |
720 |
2015-03-31 |
719 |
2014-12-31 |
718 |
2014-09-30 |
716 |
2014-06-30 |
716 |
2014-03-31 |
715 |
2013-12-31 |
714 |
2013-09-30 |
712 |
2013-06-30 |
710 |
2013-03-31 |
708 |
2012-12-31 |
713 |
2012-09-30 |
714 |
2012-06-30 |
715 |
2012-03-31 |
714 |
2011-12-31 |
701 |
2011-09-30 |
710 |
2011-06-30 |
695 |
2011-03-31 |
688 |
2010-12-31 |
683 |
2010-09-30 |
683 |
2010-06-30 |
682 |
2010-03-31 |
680 |
2009-12-31 |
671 |
2009-09-30 |
673 |
2009-06-30 |
669 |
2009-03-31 |
667 |
Sector |
Industry |
Market Cap |
Revenue |
Multi-Sector Conglomerates |
Diversified Operations |
$187.622B |
$29.453B |
Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.
|